Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03187834 · ClinicalTrials.gov registry record · Phase 4
Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso
A Phase 4 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 252
- Enrollment target
NCT03187834 is a Phase 4 study that has completed, run by University of California, San Francisco. The registered enrollment target is 252 participants.
The verdict
NCT03187834, a Phase 4 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 252 participants
- Enrollment target
Study Summary
The use of antibiotics has saved millions of human lives, however consumption of antibiotics can select for antibiotic resistant organisms and may lead to changes in commensal microbiome. This study is designed to estimate the effect of antibiotic consumption on microbiome in a rural region of rural Burkina Faso. Changes in the intestinal and nasopharyngeal microbiome and resistome following a short course of antibiotics will be measured.
Interventions
- DRUG Placebo
- DRUG Azithromycin
- DRUG Amoxicillin
- DRUG Cotrimoxazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2017-07-04 |
| Est. Completion | 2019-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03187834
The ClinicalTrials.gov registry entry for NCT03187834 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT03187834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03187834 about?
NCT03187834 is a clinical study titled "Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso". The use of antibiotics has saved millions of human lives, however consumption of antibiotics can select for antibiotic resistant organisms and may lead to changes in commensal microbiome. This study is designed to estimate the effect of antibiotic consumption on microbiome in a rural region of rural...
What is the current status of trial NCT03187834?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 252 participants. The study started on 2017-07-04. Estimated completion is 2019-09-01.
What interventions are being tested in trial NCT03187834?
The interventions under investigation include: Placebo (DRUG), Azithromycin (DRUG), Amoxicillin (DRUG), Cotrimoxazole (DRUG).
Who is sponsoring clinical trial NCT03187834?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.